The classes of biologics with approved drugs for treatment of psoriatic arthritis include: Tumor necrosis factor (TNF)-alpha ...

Hispanic and non-White patients with psoriatic arthritis (PsA) had higher tender joint counts and greater disease severity, highlighting racial and ethnic disparities in PsA disease burden and ...

A new oral treatment for psoriatic arthritis ... inadequately controlled by disease-modifying anti-rheumatic drugs (DMARDs) and/or biologics. More than 75% of patients were previously treated ...

Treatment targets & strategies Remission, or at least minimal disease activity, should be the target of all treatment strategies in psoriatic arthritis. All musculoskeletal and cutaneous ...

The study grouped 32,098 patients with psoriasis or psoriatic arthritis (PsA) into their respective categories based on biologic treatment, which included TNFi (n = 20,314), IL-17i (n = 5,073), IL ...

A deeper understanding of the inflammatory processes driving psoriasis and psoriatic ... biologic therapies offer another approach to managing patients with moderate to severe disease. These ...

Biologics are given by injection or infusion. There are several categories of these drugs: Acthar gel (repository ... for ...

Treating your rheumatoid arthritis with a biologic drug has probably been pretty effective. Biologics are designed to target inflammation and stop joint damage like a sniper in the war against RA.

Investigative therapies to treat moderate to severe plaque psoriasis in clinical trials include several orally administered ...

In recent years, there's been a revolution in Disease-Modifying Antirheumatic Drugs ... have a look at how biologics work to help correct it. ALLAN GIBOFSKY: In rheumatoid arthritis, a person's ...

Rheumatoid arthritis (RA ... Special discount programmes are available for each of the biologic DMARDs, but the high cost of these drugs limits access in the United States and elsewhere.

In a large cohort of patients with autoimmune diseases, treatment with biologic disease-modifying antirheumatic drugs was ...